<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neurophysiol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Neurophysiol</journal-id>
<journal-id journal-id-type="hwp">jn</journal-id>
<journal-id journal-id-type="pmc">jn</journal-id>
<journal-id journal-id-type="publisher-id">JN</journal-id>
<journal-title-group>
<journal-title>Journal of Neurophysiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-3077</issn>
<issn pub-type="epub">1522-1598</issn>
<publisher>
<publisher-name>American Physiological Society</publisher-name>
<publisher-loc>Bethesda, MD</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27385793</article-id>
<article-id pub-id-type="pmc">5023417</article-id>
<article-id pub-id-type="publisher-id">JN-00248-2016</article-id>
<article-id pub-id-type="doi">10.1152/jn.00248.2016</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cognitive dysfunction in Duchenne muscular dystrophy: a possible role for neuromodulatory immune molecules</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Rae</surname>
<given-names>Mark G.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-7031-4879</contrib-id>
<name>
<surname>O'Malley</surname>
<given-names>Dervla</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<aff id="aff1"><sup>1</sup>Department of Physiology, University College Cork, Cork, Ireland; and </aff>
<aff id="aff2"><sup>2</sup>APC Microbiome Institute, University College Cork, Cork, Ireland</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Address for reprint requests and other correspondence: D. O'Malley, <addr-line>Dept. of Physiology, Western Gateway Bldg., Univ. College Cork, Cork, Ireland</addr-line> (e-mail: <email>d.omalley@ucc.ie</email>).</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>6</day>
<month>7</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<day>1</day>
<month>9</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>9</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>116</volume>
<issue>3</issue>
<fpage>1304</fpage>
<lpage>1315</lpage>
<history>
<date date-type="received">
<day>23</day>
<month>3</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>6</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright Â© 2016 the American Physiological Society</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>American Physiological Society</copyright-holder>
</permissions>
<self-uri content-type="pdf" xlink:href="z9k00916001304.pdf"></self-uri>
<abstract>
<p>Duchenne muscular dystrophy (DMD) is an X chromosome-linked disease characterized by progressive physical disability, immobility, and premature death in affected boys. Underlying the devastating symptoms of DMD is the loss of dystrophin, a structural protein that connects the extracellular matrix to the cell cytoskeleton and provides protection against contraction-induced damage in muscle cells, leading to chronic peripheral inflammation. However, dystrophin is also expressed in neurons within specific brain regions, including the hippocampus, a structure associated with learning and memory formation. Linked to this, a subset of boys with DMD exhibit nonprogressing cognitive dysfunction, with deficits in verbal, short-term, and working memory. Furthermore, in the genetically comparable dystrophin-deficient <italic>mdx</italic> mouse model of DMD, some, but not all, types of learning and memory are deficient, and specific deficits in synaptogenesis and channel clustering at synapses has been noted. Little consideration has been devoted to the cognitive deficits associated with DMD compared with the research conducted into the peripheral effects of dystrophin deficiency. Therefore, this review focuses on what is known about the role of full-length dystrophin (Dp427) in hippocampal neurons. The importance of dystrophin in learning and memory is assessed, and the potential importance that inflammatory mediators, which are chronically elevated in dystrophinopathies, may have on hippocampal function is also evaluated.</p>
</abstract>
<kwd-group>
<kwd>Duchenne muscular dystrophy</kwd>
<kwd>dystrophin</kwd>
<kwd>hippocampus</kwd>
<kwd>learning</kwd>
<kwd>memory</kwd>
</kwd-group>
<funding-group>
<award-group id="award1">
<funding-source>Muscular Dystrophy Ireland</funding-source>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>